Importantly, constitutive activation of EGFR or enhanced EGF signaling is frequently found in different types of cancers, especially in lung cancer, where it is associated with cancer initiation, tumor growth/progression, metastasis and poor prognosis [17]–[20]. This evidence concerns the gene EGF and neoplasm.